Courier Health, an AI-powered biopharma platform, secured $50 million in Series B funding led by Oak HC/FT. The platform manages the end-to-end patient experience for pharmaceutical companies.
The funding round included participation from Norwest Venture Partners. Courier Health's platform addresses a critical gap in drug development and patient management by automating and optimizing the complete patient journey from prescription through treatment completion.
The company focuses on medication adherence and patient experience management, areas where pharmaceutical companies traditionally struggle. By leveraging AI, Courier Health streamlines workflows that typically involve multiple disconnected systems and manual processes.
This Series B round brings total funding to the company and validates the growing market demand for digital health solutions in the biopharma sector. The capital will likely support product expansion and go-to-market initiatives as healthcare companies increasingly prioritize patient experience metrics alongside clinical outcomes.
Courier Health joins a wave of startups modernizing pharmaceutical operations through automation and data analytics.
Town, an enterprise personal AI assistant platform, is in talks to raise funding at a $1 billion valuation in a round led by Index Ventures, according to sources.
Product management platform Linear reached $100M in annual recurring revenue and conducted a $99M employee tender offer at a $2.5B valuation, doubling its valuation from $1.25B in 2025.
Flipboard is acquiring Bluesky feed-building startup Graze, integrating its ad technology and creator monetization tools into its open social web platform.
Artificial intelligence is fundamentally changing how startups operate, not just what they build. According to Floodgate co-founder Ann Miura-Ko, companies are deploying AI agents across engineering, sales, marketing, and strategy to accelerate learning and execution.